Axa’s Concentrix CNXC Stock Holding History

Axa’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,600	Closed	-$943K	–	1076
2023 Q4	$943K	Buy	+9,600	New	+$836K	﹤0.01%	853
2021 Q1	–	Sell	-81,500	Closed	-$8.04M	–	1229
2020 Q4	$8.04M	Buy	+81,500	New	+$8.15M	0.03%	575

Other funds holding CNXC

GBL

Groupe Bruxelles Lambert Brussels, Belgium $62.2M AUM 57.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Axa's CNXC Position: Q1 2024 in Review

Axa sold out of Concentrix (CNXC) in Q1 2024, closing a stake of 9,600 shares — an estimated $943K sold.

Axa first reported a position in CNXC in Q4 2020 and held it in 2 quarters. The position peaked at $8.04M in Q4 2020. 292 funds tracked by Wall St. Rank hold CNXC as of Q1 2024.

Axa reported no remaining Concentrix position as of Q1 2024 after selling out during the quarter.
Axa sold 9,600 Concentrix shares in Q1 2024, an estimated $943K.
Axa first reported a position in Concentrix in Q4 2020 and held it in 2 quarters.
Axa's Concentrix position peaked at $8.04M in Q4 2020.
292 funds tracked by Wall St. Rank held Concentrix as of Q1 2024.

Based on Axa's 13F filing for Q1 2024, filed 15 May 2024.